Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

IRON SUCROSE

IRON SUCROSE

Standard Dose
EQ 200MG IRON/10ML (EQ 20MG IRON/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview IRON SUCROSE is listed in Drugs@FDA under application 212559 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IRON SUCROSE Form and strength INJECTABLE;INTRAVENOUS - EQ 200MG IRON/10ML (EQ 20MG IRON/ML) Sponsor MYLAN LABS LTD Submission history Latest submission status date: 2025-08-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview IRON SUCROSE is listed in Drugs@FDA under application 212559 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IRON SUCROSE Form and strength INJECTABLE;INTRAVENOUS - EQ 200MG IRON/10ML (EQ 20MG IRON/ML) Sponsor MYLAN LABS LTD Submission history Latest submission status date: 2025-08-08 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.